ALISA DAVIDOVA: Open Payments
NPI 1639755457 · ENGLISHTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 53 payments from 13 companies in 2025. Trend: 2023 $336 · 2024 $744 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $303 |
| ABBVIE INC. | 11 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Ardelyx, Inc. | 3 | $63 |
| GENZYME CORPORATION | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 5 | $51 |
| Madrigal Pharmaceuticals | 3 | $48 |
| Lilly USA, LLC | 2 | $42 |
| Exact Sciences Corporation | 1 | $28 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, ENTYVIO, IBSRELA, RINVOQ, LINZESS, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
